Ads
related to: biogen's alzheimer's drug- About Treatment
Learn more about the Alzheimer's
treatment option & how it works.
- Alzheimer's Disease Info
Learn about the stages of AD and
diagnostic tests for patients.
- Support & Resources
Patient and care partner support
available on the treatment website.
- For Care Partners
Help support your loved one. View
tips and infusion companion info.
- Getting Started
Find infusion FAQs & tips for
getting started with treatment.
- Sign Up For More Info
Get access to information all about
treatment & useful tips.
- About Treatment
Search results
South Korea’s MFDS approves Eisai-Biogen’s LEQEMBI for Alzheimer’s
Pharmaceutical Technology via Yahoo Finance· 5 days agoAdditionally, the rolling submission of a biologics license application (BLA) for a subcutaneous...
Biogen (BIIB) Gets EU Approval for Rare Disease Drug Qalsody
Zacks via Yahoo Finance· 19 hours agoBiogen’s stock was up 2.6% on Thursday in response to Qalsody’s approval in the EU. Biogen’s stock...
Is Biogen Inc (BIIB) Set to Underperform? Analyzing the Factors
Guru Focus· 18 hours agoLong-established in the Drug Manufacturers industry, Biogen Inc (BIIB, Financial) has enjoyed a stellar reputation. Notably, its diminished rankings in financial strength, ...
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a...
Morningstar· 1 day agoGlancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Biogen Inc. (BIIB) Investors Glancy Prongay & Murray LLP (“GPM ...
Is Eli Lilly Stock A Buy On A Recent Crohn's Disease-Related Rally?
Investor's Business Daily· 2 days agoThe decision effectively pushes back the approval decision, which was expected in the first quarter....
Biogen's new acquisition target reveals 'provocative' trial results - Boston Business Journal
The Business Journals· 4 days agoThe data comes from aa ongoing Phase 2 study of the drug felzartamab to treat IgA nephropathy, a...
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Biogen...
Morningstar· 2 days agoPomerantz LLP announces that a class action lawsuit has been filed against Biogen Inc. ("Biogen" or the "Company") (NASDAQ: BIIB) and certain officers. The class action, filed in the United ...
BIIB INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Biogen, Inc. Investors with...
Benzinga· 7 days agoCaptioned Gray v. Biogen Inc., No. 24-cv-01444 (D. Colo.), the Biogen class action lawsuit charges Biogen and certain of Biogen's top current and former ...
